[1] Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW, Malkin D, Taylor MD, Gajjar A, Pfister SM. Medulloblastoma[J]. Nat Rev Dis Primers, 2019, 5:11.
[2] Quinlan A, Rizzolo D. Understanding medulloblastoma[J]. JAAPA, 2017, 30:30-36.
[3] Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, Kool M, Dufour C, Vassal G, Milde T, Witt O, von Hoff K, Pietsch T, Northcott PA, Gajjar A, Robinson GW, Padovani L, André N, Massimino M, Pizer B, Packer R, Rutkowski S, Pfister SM, Taylor MD, Pomeroy SL. Risk stratification of childhood medulloblastoma in the molecular era:the current consensus[J]. Acta Neuropathol, 2016, 131:821-831.
[4] Gerber NU, Mynarek M, von Hoff K, Friedrich C, Resch A, Rutkowski S. Recent developments and current concepts in medulloblastoma[J]. Cancer Treat Rev, 2014, 40:356-365.
[5] Bleil CB, Bizzi JWJ, Bedin A, de Oliveira FH, Antunes Á C. Survival and prognostic factors in childhood medulloblastoma:a Brazilian single center experience from 1995 to 2016[J]. Surg Neurol Int, 2019, 10:120.
[6] Cassia GS, Alves CA, Taranath A, López NS, Oztekin O, Goncalves FG, Patay Z. Childhood medulloblastoma revisited[J]. Top Magn Reson Imaging,2018, 27:479-502.
[7] Pugh TJ, Weeraratne SD, Archer TC, Pomeranz Krummel DA, Auclair D, Bochicchio J, Carneiro MO, Carter SL, Cibulskis K, Erlich RL, Greulich H, Lawrence MS, Lennon NJ, McKenna A, Meldrim J, Ramos AH, Ross MG, Russ C, Shefler E, Sivachenko A, Sogoloff B, Stojanov P, Tamayo P, Mesirov JP, Amani V, Teider N, Sengupta S, Francois JP, Northcott PA, Taylor MD, Yu F, Crabtree GR, Kautzman AG, Gabriel SB, Getz G, J äger N, Jones DT, Lichter P, Pfister SM, Roberts TM, Meyerson M, Pomeroy SL, Cho YJ. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations[J]. Nature, 2012, 488:106-110.
[8] Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, Pfister SM. Molecular subgroups of medulloblastoma:the current consensus[J]. Acta Neuropathol, 2012, 123:465-472.
[9] Bouffet E. Management of high-risk medulloblastoma[J]. Neurochirurgie, 2019.[Epub ahead of print]
[10] Yu JZ, Li H. The expression of FAT1 is associated with overall survival in children with medulloblastoma[J]. Tumori, 2017, 103:44-52.
[11] Borkosky SS, Gunduz M, Nagatsuka H, Beder LB, Gunduz E, Ali MA, Rodriguez AP, Cilek MZ, Tominaga S, Yamanaka N, Shimizu K, Nagai N. Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma[J]. J Cancer Res Clin Oncol, 2009, 135:703-713.
[12] Morris LG, Kaufman AM, Gong Y, Ramaswami D, Walsh LA, Turcan ?, Eng S, Kannan K, Zou Y, Peng L, Banuchi VE, Paty P, Zeng Z, Vakiani E, Solit D, Singh B, Ganly I, Liau L, Cloughesy TC, Mischel PS, Mellinghoff IK, Chan TA. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation[J]. Nat Genet, 2013, 45:253-261.
[13] Katoh M. Function and cancer genomics of FAT family genes (review)[J]. Int J Oncol, 2012, 41:1913-1918.
[14] Nishikawa Y, Miyazaki T, Nakashiro K, Yamagata H, Isokane M, Goda H, Tanaka H, Oka R, Hamakawa H. Human FAT1 cadherin controls cell migration and invasion of oral squamous cell carcinoma through the localization of beta-catenin[J]. Oncol Rep, 2011, 26:587-592.
[15] Li ZX, Liu B, Yang L, Wang HJ, Zhou WH. Evaluation of diagnostic accuracy of the whole-exome data analysis pipeline of Children's Hospital of Fudan University[J]. Zhongguo Xun Zheng Er Ke Za Zhi, 2015, 10:25-28.[黎籽秀, 刘博, 杨琳, 王慧君, 周文浩. 高通量测序数据分析和临床诊断流程对新生儿多发畸形候选变异的筛选准确性研究[J]. 中国循证儿科杂志, 2015, 10:25-28.]
[16] Juraschka K, Taylor MD. Medulloblastoma in the age of molecular subgroups:a review[J]. J Neurosurg Pediatr, 2019, 24:353-363.
[17] Northcott PA, Korshunov A, Witt H, Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins CE, French P, Rutka JT, Pfister S, Taylor MD. Medulloblastoma comprises four distinct molecular variants[J]. J Clin Oncol, 2011, 29:1408-1414.
[18] Kijima N, Kanemura Y. Molecular classification of medulloblastoma[J]. Neurol Med Chir (Tokyo), 2016, 56:687-697.
[19] Tanoue T, Takeichi M. Mammalian FAT1 cadherin regulates actin dynamics and cell-cell contact[J]. J Cell Biol, 2004, 165:517-528. |